"NIH Unveils AI Tool to Predict Cancer Immunotherapy Outcomes"
TL;DR
NIH researchers have developed an AI tool, LORIS, that uses routine clinical data to predict cancer patients' responses to immune checkpoint inhibitors, potentially improving treatment decisions. The model, which includes factors like age, cancer type, and blood markers, was validated using data from 2,881 patients and is publicly available for further clinical evaluation.
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy National Institutes of Health (NIH) (.gov)
Want the full story? Read the original reporting
Read on National Institutes of Health (NIH) (.gov)